Preventive Maintenance and Repair Service Agreement for Emulate ZOE CM1 and CM2 Culture Modules

The contract solicitation for Preventive Maintenance and Repair Service Agreement for Emulate ZOE CM1 and CM2 Culture Modules under solicitation number 75F40126Q132585 is a commercial item, firm fixed price acquisition issued by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The scope requires on-site preventive maintenance service for four specific instrument units—two CM1 models (ZOE-CM1 00142 and ZOE-CM1-00141) and two CM2 models (ZOE-CM2-00237 and ZOE-CM2 00235)—with one scheduled annual visit per unit, including functional quality control testing, technical support via manufacturer senior engineers during standard business hours excluding federal holidays, and submission of standardized service reports after each visit. Services must ensure compatibility with lung and blood-milk barrier MPS chips and compound distribution kits used in drug absorption studies. The period of performance is one year, commencing July 15, 2026, and ending July 14, 2027, with all work performed at the FDA White Oak Campus in Silver Spring, Maryland. All shipping and handling must be included in the quoted price, and services cannot be scheduled during federal holidays or without prior authorization from the Project Lead. Proposals must be submitted electronically via email to Nick Sartain at nick.sartain@fda.hhs.gov by the revised deadline of June 30, 2026, at 10:00 AM Central Time, and all submissions must reference the solicitation number and include the offeror’s SAM Unique Entity ID. Offerors are required to submit an accessibility conformance report for any non-compliant items, adhere to Section 508 accessibility standards, and comply with Buy American Act and Trade Agreements Act requirements. The contract incorporates multiple FAR and HHSAR clauses including deviations related to commercial item terms, whistleblower rights, subcontracting, payment by electronic funds transfer, accelerated payments to small business subcontractors, and prohibitions on inverted corporations and internal confidentiality agreements. Payment is strictly net 30 days after government acceptance, with no advance payments allowed, and invoicing must be done through the Treasury’s IPP system with detailed supporting documentation. Evaluation is based on a most advantageous to the government determination, where technical capability and past performance collectively carry greater weight than price, but price becomes the deciding factor